Chemokines and cytokines in neuroinflammation leading to neuropathic pain

Current Opinion in Pharmacology

Volumn 12, Issue 1, 2012, Pages 55-61

  Kiguchi, Norikazu ^a   Kobayashi, Yuka ^a   Kishioka, Shiroh ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; CHEMOKINE; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CX3CR1; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR4; CXCL2 CHEMOKINE; CYTOKINE; FRACTALKINE; INTERFERON; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES; SECONDARY LYMPHOID TISSUE CHEMOKINE; STAT3 PROTEIN; STROMAL CELL DERIVED FACTOR 1; TUMOR NECROSIS FACTOR ALPHA; VANILLOID RECEPTOR 1;

ASTROCYTE; CELL ACTIVATION; CORRELATION ANALYSIS; HUMAN; MICROGLIA; NERVE CELL; NERVE INJURY; NERVOUS SYSTEM INFLAMMATION; NEUROPATHIC PAIN; NEUTROPHIL CHEMOTAXIS; NOCICEPTION; NOCICEPTIVE RECEPTOR; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SCHWANN CELL; SENSITIZATION; SIGNAL TRANSDUCTION; SPINAL CORD DORSAL HORN; SPINAL GANGLION;

CYTOKINES; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; NEURALGIA; SIGNAL TRANSDUCTION;

EID: 84857236125     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2011.10.007     Document Type: Review

References (89)

1. R. Baron, A. Binder, and G. Wasner Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment Lancet Neurol 9 2010 807 819
2. R. Baron Mechanisms of disease: neuropathic pain - a clinical perspective Nat Clin Pract Neurol 2 2006 95 106
3. N.B. Finnerup, S.H. Sindrup, and T.S. Jensen The evidence for pharmacological treatment of neuropathic pain Pain 150 2010 573 581
4. I. Gilron, J.M. Bailey, D. Tu, R.R. Holden, D.F. Weaver, and R.L. Houlden Morphine, gabapentin, or their combination for neuropathic pain N Engl J Med 352 2005 1324 1334
5. N.B. Finnerup, M. Otto, H.J. McQuay, T.S. Jensen, and S.H. Sindrup Algorithm for neuropathic pain treatment: an evidence based proposal Pain 118 2005 289 305
6. J.N. Campbell, and R.A. Meyer Mechanisms of neuropathic pain Neuron 52 2006 77 92
7. Z. Seltzer, R. Dubner, and Y. Shir A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury Pain 43 1990 205 218
8. K. Ren, and R. Dubner Interactions between the immune and nervous systems in pain Nat Med 16 2010 1267 1276
9. J. Scholz, and C.J. Woolf The neuropathic pain triad: neurons, immune cells and glia Nat Neurosci 10 2007 1361 1368
10. M.A. Thacker, A.K. Clark, F. Marchand, and S.B. McMahon Pathophysiology of peripheral neuropathic pain: immune cells and molecules Anesth Analg 105 2007 838 847
11. G. Moalem, and D.J. Tracey Immune and inflammatory mechanisms in neuropathic pain Brain Res Rev 51 2006 240 264
12. E.D. Milligan, and L.R. Watkins Pathological and protective roles of glia in chronic pain Nat Rev Neurosci 10 2009 23 36
13. K. Inoue, and M. Tsuda Microglia and neuropathic pain Glia 57 2009 1469 1479
14. F. Marchand, M. Perretti, and S.B. McMahon Role of the immune system in chronic pain Nat Rev Neurosci 6 2005 521 532
15. M.G. Netea, J.W. van der Meer, M. van Deuren, and B.J. Kullberg Proinflammatory cytokines and sepsis syndrome: not enough, or too much of a good thing? Trends Immunol 24 2003 254 258
16. M. Gouwy, S. Struyf, P. Proost, and J. Van Damme Synergy in cytokine and chemokine networks amplifies the inflammatory response Cytokine Growth Factor Rev 16 2005 561 580
17. A. Mantovani, A. Sica, S. Sozzani, P. Allavena, A. Vecchi, and M. Locati The chemokine system in diverse forms of macrophage activation and polarization Trends Immunol 25 2004 677 686
18. C.A. Dinarello Interleukin-1 in the pathogenesis and treatment of inflammatory diseases Blood 117 2011 3720 3732
19. X. Bosch, A. Saiz, and M. Ramos-Casals Monoclonal antibody therapy-associated neurological disorders Nat Rev Neurol 7 2011 165 172
20. C. Gabay, C. Lamacchia, and G. Palmer IL-1 pathways in inflammation and human diseases Nat Rev Rheumatol 6 2010 232 241
21. R.M. Ransohoff Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology Immunity 31 2009 711 721
22. I.F. Charo, and R.M. Ransohoff The many roles of chemokines and chemokine receptors in inflammation N Engl J Med 354 2006 610 621
23. E.E. Ubogu, M.B. Cossoy, and R.M. Ransohoff The expression and function of chemokines involved in CNS inflammation Trends Pharmacol Sci 27 2006 48 55
24. B. Moser, M. Wolf, A. Walz, and P. Loetscher Chemokines: multiple levels of leukocyte migration control Trends Immunol 25 2004 75 84
25. S.L. Deshmane, S. Kremlev, S. Amini, and B.E. Sawaya Monocyte chemoattractant protein-1 (MCP-1): an overview J Interferon Cytokine Res 29 2009 313 326
26. P. Menten, A. Wuyts, and J. Van Damme Macrophage inflammatory protein-1 Cytokine Growth Factor Rev 13 2002 455 481
27. F. Cocchi, A.L. DeVico, A. Garzino-Demo, S.K. Arya, R.C. Gallo, and P. Lusso Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells Science 270 1995 1811 1815
28. P. Romagnani, L. Lasagni, F. Annunziato, M. Serio, and S. Romagnani CXC chemokines: the regulatory link between inflammation and angiogenesis Trends Immunol 25 2004 201 209
29. B.A. Jones, M. Beamer, and S. Ahmed Fractalkine/CX3CL1: a potential new target for inflammatory diseases Mol Interv 10 2010 263 270
30. A.K. Clark, P.K. Yip, and M. Malcangio The liberation of fractalkine in the dorsal horn requires microglial cathepsin S J Neurosci 29 2009 6945 6954
31. C. Palmqvist, A.J. Wardlaw, and P. Bradding Chemokines and their receptors as potential targets for the treatment of asthma Br J Pharmacol 151 2007 725 736
32. S. Sorce, R. Myburgh, and K.H. Krause The chemokine receptor CCR5 in the central nervous system Prog Neurobiol 93 2011 297 311
33. G. Lazennec, and A. Richmond Chemokines and chemokine receptors: new insights into cancer-related inflammation Trends Mol Med 16 2010 133 144
34. K.L. Jones, J.J. Maguire, and A.P. Davenport Chemokine receptor CCR5: from AIDS to atherosclerosis Br J Pharmacol 162 2011 1453 1469
35. C. Abbadie Chemokines, chemokine receptors and pain Trends Immunol 26 2005 529 534
36. S.B. Oh, P.B. Tran, S.E. Gillard, R.W. Hurley, D.L. Hammond, and R.J. Miller Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons J Neurosci 21 2001 5027 5035
37. C. Abbadie, J.A. Lindia, A.M. Cumiskey, L.B. Peterson, J.S. Mudgett, E.K. Bayne, J.A. DeMartino, D.E. MacIntyre, and M.J. Forrest Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2 Proc Natl Acad Sci USA 100 2003 7947 7952
38. N. Kiguchi, Y. Kobayashi, T. Maeda, F. Saika, and S. Kishioka CC-chemokine MIP-1alpha in the spinal cord contributes to nerve injury-induced neuropathic pain Neurosci Lett 484 2010 17 21
39. Y.J. Gao, L. Zhang, O.A. Samad, M.R. Suter, K. Yasuhiko, Z.Z. Xu, J.Y. Park, A.L. Lind, Q. Ma, and R.R. Ji JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain J Neurosci 29 2009 4096 4108
40. F.A. White, S.K. Bhangoo, and R.J. Miller Chemokines: integrators of pain and inflammation Nat Rev Drug Discov 4 2005 834 844
41. M.N. Manjavachi, N.L. Quintao, M.M. Campos, I.K. Deschamps, R.A. Yunes, R.J. Nunes, P.C. Leal, and J.B. Calixto The effects of the selective and non-peptide CXCR2 receptor antagonist SB225002 on acute and long-lasting models of nociception in mice Eur J Pain 14 2010 23 31
42. H.L. Rittner, D. Labuz, M. Schaefer, S.A. Mousa, S. Schulz, M. Schafer, C. Stein, and A. Brack Pain control by CXCR2 ligands through Ca2+-regulated release of opioid peptides from polymorphonuclear cells FASEB J 20 2006 2627 2629
43. F.A. White, P. Feldman, and R.J. Miller Chemokine signaling and the management of neuropathic pain Mol Interv 9 2009 188 195
44. M. Mueller, K. Wacker, E.B. Ringelstein, W.F. Hickey, Y. Imai, and R. Kiefer Rapid response of identified resident endoneurial macrophages to nerve injury Am J Pathol 159 2001 2187 2197
45. N.M. Perkins, and D.J. Tracey Hyperalgesia due to nerve injury: role of neutrophils Neuroscience 101 2000 745 757
46. O. Soehnlein, C. Weber, and L. Lindbom Neutrophil granule proteins tune monocytic cell function Trends Immunol 30 2009 538 546
47. O. Soehnlein, L. Lindbom, and C. Weber Mechanisms underlying neutrophil-mediated monocyte recruitment Blood 114 2009 4613 4623
48. P. Hu, and E.M. McLachlan Macrophage and lymphocyte invasion of dorsal root ganglia after peripheral nerve lesions in the rat Neuroscience 112 2002 23 38
49. T. Liu, N. van Rooijen, and D.J. Tracey Depletion of macrophages reduces axonal degeneration and hyperalgesia following nerve injury Pain 86 2000 25 32
50. G. Moalem, K. Xu, and L. Yu T lymphocytes play a role in neuropathic pain following peripheral nerve injury in rats Neuroscience 129 2004 767 777
51. S. Shamash, F. Reichert, and S. Rotshenker The cytokine network of Wallerian degeneration: tumor necrosis factor-alpha, interleukin-1alpha, and interleukin-1beta J Neurosci 22 2002 3052 3060
52. K. Okamoto, D.P. Martin, J.D. Schmelzer, Y. Mitsui, and P.A. Low Pro- and anti-inflammatory cytokine gene expression in rat sciatic nerve chronic constriction injury model of neuropathic pain Exp Neurol 169 2001 386 391
53. N. Kiguchi, T. Maeda, Y. Kobayashi, Y. Fukazawa, and S. Kishioka Macrophage inflammatory protein-1alpha mediates the development of neuropathic pain following peripheral nerve injury through interleukin-1beta up-regulation Pain 149 2010 305 315
54. A.M. Binshtok, H. Wang, K. Zimmermann, F. Amaya, D. Vardeh, L. Shi, G.J. Brenner, R.R. Ji, B.P. Bean, and C.J. Woolf Nociceptors are interleukin-1beta sensors J Neurosci 28 2008 14062 14073
55. G. Wolf, E. Gabay, M. Tal, R. Yirmiya, and Y. Shavit Genetic impairment of interleukin-1 signaling attenuates neuropathic pain, autotomy, and spontaneous ectopic neuronal activity, following nerve injury in mice Pain 120 2006 315 324
56. M.S. Ramer, P.G. Murphy, P.M. Richardson, and M.A. Bisby Spinal nerve lesion-induced mechanoallodynia and adrenergic sprouting in sensory ganglia are attenuated in interleukin-6 knockout mice Pain 78 1998 115 121
57. M. Zelenka, M. Schafers, and C. Sommer Intraneural injection of interleukin-1beta and tumor necrosis factor-alpha into rat sciatic nerve at physiological doses induces signs of neuropathic pain Pain 116 2005 257 263
58. F.A. White, J. Sun, S.M. Waters, C. Ma, D. Ren, M. Ripsch, J. Steflik, D.N. Cortright, R.H. Lamotte, and R.J. Miller Excitatory monocyte chemoattractant protein-1 signaling is up-regulated in sensory neurons after chronic compression of the dorsal root ganglion Proc Natl Acad Sci USA 102 2005 14092 14097
59. G.K. Tofaris, P.H. Patterson, K.R. Jessen, and R. Mirsky Denervated Schwann cells attract macrophages by secretion of leukemia inhibitory factor (LIF) and monocyte chemoattractant protein-1 in a process regulated by interleukin-6 and LIF J Neurosci 22 2002 6696 6703
60. F.E. Perrin, S. Lacroix, M. Aviles-Trigueros, and S. David Involvement of monocyte chemoattractant protein-1, macrophage inflammatory protein-1alpha and interleukin-1beta in Wallerian degeneration Brain 128 2005 854 866
61. N. Zhang, S. Inan, A. Cowan, R. Sun, J.M. Wang, T.J. Rogers, M. Caterina, and J.J. Oppenheim A proinflammatory chemokine, CCL3, sensitizes the heat- and capsaicin-gated ion channel TRPV1 Proc Natl Acad Sci USA 102 2005 4536 4541
62. F.E. Holmes, N. Arnott, P. Vanderplank, N.C. Kerr, E.E. Longbrake, P.G. Popovich, T. Imai, C. Combadiere, P.M. Murphy, and D. Wynick Intra-neural administration of fractalkine attenuates neuropathic pain-related behaviour J Neurochem 106 2008 640 649
63. M. Inui, Y. Ishida, A. Kimura, Y. Kuninaka, N. Mukaida, and T. Kondo Protective roles of CX3CR1-mediated signals in toxin A-induced enteritis through the induction of heme oxygenase-1 expression J Immunol 186 2011 423 431
64. A.E. Cardona, E.P. Pioro, M.E. Sasse, V. Kostenko, S.M. Cardona, I.M. Dijkstra, D. Huang, G. Kidd, S. Dombrowski, and R. Dutta Control of microglial neurotoxicity by the fractalkine receptor Nat Neurosci 9 2006 917 924
65. Y.J. Gao, and R.R. Ji Chemokines, neuronal-glial interactions, and central processing of neuropathic pain Pharmacol Ther 126 2010 56 68
66. M. Tsuda, Y. Shigemoto-Mogami, S. Koizumi, A. Mizokoshi, S. Kohsaka, M.W. Salter, and K. Inoue P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury Nature 424 2003 778 783
67. R. Fujita, Y. Ma, and H. Ueda Lysophosphatidic acid-induced membrane ruffling and brain-derived neurotrophic factor gene expression are mediated by ATP release in primary microglia J Neurochem 107 2008 152 160
68. M. Tsuda, T. Masuda, J. Kitano, H. Shimoyama, H. Tozaki-Saitoh, and K. Inoue IFN-gamma receptor signaling mediates spinal microglia activation driving neuropathic pain Proc Natl Acad Sci USA 106 2009 8032 8037
69. P. Vanelderen, T. Rouwette, T. Kozicz, E. Roubos, J. Van Zundert, R. Heylen, and K. Vissers The role of brain-derived neurotrophic factor in different animal models of neuropathic pain Eur J Pain 14 2010 473 e471-479
70. J.A. Coull, S. Beggs, D. Boudreau, D. Boivin, M. Tsuda, K. Inoue, C. Gravel, M.W. Salter, and Y. De Koninck BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain Nature 438 2005 1017 1021
71. K. Miyoshi, K. Obata, T. Kondo, H. Okamura, and K. Noguchi Interleukin-18-mediated microglia/astrocyte interaction in the spinal cord enhances neuropathic pain processing after nerve injury J Neurosci 28 2008 12775 12787
72. J. Van Steenwinckel, A. Reaux-Le Goazigo, B. Pommier, A. Mauborgne, M.A. Dansereau, P. Kitabgi, P. Sarret, M. Pohl, and S. Melik Parsadaniantz CCL2 released from neuronal synaptic vesicles in the spinal cord is a major mediator of local inflammation and pain after peripheral nerve injury J Neurosci 31 2011 5865 5875
73. M.A. Thacker, A.K. Clark, T. Bishop, J. Grist, P.K. Yip, L.D. Moon, S.W. Thompson, F. Marchand, and S.B. McMahon CCL2 is a key mediator of microglia activation in neuropathic pain states Eur J Pain 13 2009 263 272
74. J. Zhang, X.Q. Shi, S. Echeverry, J.S. Mogil, Y. De Koninck, and S. Rivest Expression of CCR2 in both resident and bone marrow-derived microglia plays a critical role in neuropathic pain J Neurosci 27 2007 12396 12406
75. M.E. Dorf, M.A. Berman, S. Tanabe, M. Heesen, and Y. Luo Astrocytes express functional chemokine receptors J Neuroimmunol 111 2000 109 121
76. E.W. Boddeke, I. Meigel, S. Frentzel, N.G. Gourmala, J.K. Harrison, M. Buttini, O. Spleiss, and P. Gebicke-Harter Cultured rat microglia express functional beta-chemokine receptors J Neuroimmunol 98 1999 176 184
77. K. Biber, M. Tsuda, H. Tozaki-Saitoh, K. Tsukamoto, E. Toyomitsu, T. Masuda, H. Boddeke, and K. Inoue Neuronal CCL21 up-regulates microglia P2X4 expression and initiates neuropathic pain development EMBO J 30 2011 1864 1873
78. A.A. Staniland, A.K. Clark, R. Wodarski, O. Sasso, F. Maione, F. D'Acquisto, and M. Malcangio Reduced inflammatory and neuropathic pain and decreased spinal microglial response in fractalkine receptor (CX3CR1) knockout mice J Neurochem 114 2010 1143 1157
79. F.A. White, H. Jung, and R.J. Miller Chemokines and the pathophysiology of neuropathic pain Proc Natl Acad Sci USA 104 2007 20151 20158
80. A.K. Clark, P.K. Yip, J. Grist, C. Gentry, A.A. Staniland, F. Marchand, M. Dehvari, G. Wotherspoon, J. Winter, and J. Ullah Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain Proc Natl Acad Sci USA 104 2007 10655 10660
81. F. Lago, C. Dieguez, J. Gomez-Reino, and O. Gualillo Adipokines as emerging mediators of immune response and inflammation Nat Clin Pract Rheumatol 3 2007 716 724
82. T. Maeda, N. Kiguchi, Y. Kobayashi, T. Ikuta, M. Ozaki, and S. Kishioka Leptin derived from adipocytes in injured peripheral nerves facilitates development of neuropathic pain via macrophage stimulation Proc Natl Acad Sci USA 106 2009 13076 13081
83. G. Lim, S. Wang, Y. Zhang, Y. Tian, and J. Mao Spinal leptin contributes to the pathogenesis of neuropathic pain in rodents J Clin Invest 119 2009 295 304
84. N. Kiguchi, T. Maeda, Y. Kobayashi, Y. Fukazawa, and S. Kishioka Leptin enhances CC-chemokine ligand expression in cultured murine macrophage Biochem Biophys Res Commun 384 2009 311 315
85. F. Lago, C. Dieguez, J. Gomez-Reino, and O. Gualillo The emerging role of adipokines as mediators of inflammation and immune responses Cytokine Growth Factor Rev 18 2007 313 325
86. J. Qiu, W.B. Cafferty, S.B. McMahon, and S.W. Thompson Conditioning injury-induced spinal axon regeneration requires signal transducer and activator of transcription 3 activation J Neurosci 25 2005 1645 1653
87. M. Tsuda, Y. Kohro, T. Yano, T. Tsujikawa, J. Kitano, H. Tozaki-Saitoh, S. Koyanagi, S. Ohdo, R.R. Ji, and M.W. Salter JAK-STAT3 pathway regulates spinal astrocyte proliferation and neuropathic pain maintenance in rats Brain 134 2011 1127 1139
88. E. Dominguez, A. Mauborgne, J. Mallet, M. Desclaux, and M. Pohl SOCS3-mediated blockade of JAK/STAT3 signaling pathway reveals its major contribution to spinal cord neuroinflammation and mechanical allodynia after peripheral nerve injury J Neurosci 30 2010 5754 5766
89. E. Dominguez, C. Rivat, B. Pommier, A. Mauborgne, and M. Pohl JAK/STAT3 pathway is activated in spinal cord microglia after peripheral nerve injury and contributes to neuropathic pain development in rat J Neurochem 107 2008 50 60